SOLARA ACTIVE PHARMA SCIENCESSOLARA ACTIVE PHARMA SCIENCESSOLARA ACTIVE PHARMA SCIENCES

SOLARA ACTIVE PHARMA SCIENCES

No trades
See on Supercharts
Market capitalization
‪22.93 B‬INR
−1.10INR
‪5.40 M‬INR
‪12.84 B‬INR
‪21.16 M‬
Beta (1Y)
1.12

About SOLARA ACTIVE PHARMA SCIENCES


CEO
Sandeep Rao
Headquarters
Chennai
Founded
2017
ISIN
IN9624Z01022
FIGI
BBG01MSZSSQ2
Solara Active Pharma Sciences Ltd. engages in the manufacture and development of active pharmaceutical ingredient. Its products include Albendazole, aprepitant, artesunate, brivaracetam, bumetanide, buspiron, cetirizine dihydrochloride, chlorpromazine, cinacalcet hydrochloride, citicoline sodium, colchicine, colesevelam, colestipol, cycloserine, dipyridamole, disulfiram, dolutegravir, edaravone, efinaconazole, ethacrynic acid, etomidate, felbamate, flecainide acetate, flucytosine, gabapentin, hydralazine, ibuprofen, imiquimod, indapamide, lanthanum carbonate octahydrate,levetiracetam, lurasidone, mebendazole, mefenamic acid, mesalamine, mesna, methohexital, methoxsalen, mirabegron, mycophenolate mofetil, naproxen base, nizatidine, obeticholic acid, alanzapine, patiromer sorbitex calcium, pentoxifyline, pitavastatin calcium, posaconazole, praziquantel, ranitidine, rebamipide, rifaximin, rotigotine, safinamide, sapropterin, sevelamer carbonate, succinylcholine, sucroferric oxyhydroxide, sugammadex, tioconazole, tranexamic acid and zileuton. The company was founded on February 23, 2017 and is headquartered in Chennai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as SOLARAPP.

Frequently Asked Questions


The current price of SOLARAPP is 344.15 INR — it has decreased by −7.98% in the past 24 hours. Watch SOLARA ACTIVE PHARMA SCIENCES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange SOLARA ACTIVE PHARMA SCIENCES stocks are traded under the ticker SOLARAPP.
SOLARAPP stock has risen by 31.96% compared to the previous week, the month change is a 31.96% rise, over the last year SOLARA ACTIVE PHARMA SCIENCES has showed a 61.01% increase.
SOLARAPP reached its all-time high on Dec 9, 2024 with the price of 560.85 INR, and its all-time low was 201.25 INR and was reached on Jun 28, 2024. View more price dynamics on SOLARAPP chart.
See other stocks reaching their highest and lowest prices.
SOLARAPP stock is 11.07% volatile and has beta coefficient of 1.12. Track SOLARA ACTIVE PHARMA SCIENCES stock price on the chart and check out the list of the most volatile stocks — is SOLARA ACTIVE PHARMA SCIENCES there?
Today SOLARA ACTIVE PHARMA SCIENCES has the market capitalization of ‪22.93 B‬, it has increased by 13.83% over the last week.
Yes, you can track SOLARA ACTIVE PHARMA SCIENCES financials in yearly and quarterly reports right on TradingView.
SOLARAPP net income for the last quarter is ‪−21.00 M‬ INR, while the quarter before that showed ‪80.90 M‬ INR of net income which accounts for −125.96% change. Track more SOLARA ACTIVE PHARMA SCIENCES financial stats to get the full picture.
No, SOLARAPP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SOLARA ACTIVE PHARMA SCIENCES EBITDA is ‪2.06 B‬ INR, and current EBITDA margin is 16.07%. See more stats in SOLARA ACTIVE PHARMA SCIENCES financial statements.
Like other stocks, SOLARAPP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SOLARA ACTIVE PHARMA SCIENCES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SOLARA ACTIVE PHARMA SCIENCES technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SOLARA ACTIVE PHARMA SCIENCES stock shows the sell signal. See more of SOLARA ACTIVE PHARMA SCIENCES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.